Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV

Journal: Nature Medicine

Published: 2019-10-07

DOI: 10.1038/s41591-019-0602-4

Affiliations: 17

Authors: 18

Go to article
Institutions Share
Laboratory of Experimental Immunology, UoC, Germany 0.18
Institute of Virology, UoC, Germany 0.18
Department of Structural Biology, WIS, Israel 0.11
Department of Computer Science, Uni Tübingen, Germany 0.07
DZIF Partner Site Giessen-Marburg-Langen, Germany 0.06
Department of Chemical Research Support, WIS, Israel 0.06
Institute for Virology, Uni Marburg, Germany 0.06
University Hospital Frankfurt, GU, Germany 0.06
DZIF Partner Site Bonn-Cologne, Germany 0.04
University Medical Center Hamburg-Eppendorf (UKE), UHH, Germany 0.04
Bernhard Nocht Institute for Tropical Medicine (BNITM), Germany 0.04
DZIF Partner Site Hamburg-Lübeck-Borstel-Riems, Germany 0.04
Faculty of Medicine, Uni Tübingen, Germany 0.02
DZIF Partner Site Tübingen, Germany 0.02
Innere Medizin I - Onkologie, Hämatologie, Klinische Infektiologie, Klinische Immunologie, Hämostaseologie, Internistische Intensivmedizin, Germany 0.01
Center for Molecular Medicine Cologne (CMMC), UoC, Germany 0.01
University Hospital of Cologne, Germany 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER